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Abstract: This paper describes two phases of a community-directed intervention to address
strongyloidiasis in the remote Aboriginal community of Woorabinda in central Queensland,
Australia. The first phase provides the narrative of a community-driven ‘treat-and-test’ mass drug
administration (MDA) intervention that was co-designed by the Community Health Service and
the community. The second phase is a description of the re-engagement of the community in order
to disseminate the key factors for success in the previous MDA for Strongyloides stercoralis, as this
information was not shared or captured in the first phase. During the first phase in 2004, there was
a high prevalence of strongyloidiasis (12% faecal examination, 30% serology; n = 944 community
members tested) that resulted in increased morbidity and at least one death in the community.
Between 2004–2005, the community worked in partnership with the Community Health Service
to implement a S. stercoralis control program, where all of the residents were treated with oral
ivermectin, and repeat doses were given for those with positive S. stercoralis serology. The community
also developed their own health promotion campaign using locally-made resources targeting relevant
environmental health problems and concerns. Ninety-two percent of the community residents
participated in the program, and the prevalence of strongyloidiasis at the time of the ‘treat-and-test’
intervention was 16.6% [95% confidence interval 14.2–19.3]. The cure rate after two doses of ivermectin
was 79.8%, based on pre-serology and post-serology tests. The purpose of this paper is to highlight
the importance of local Aboriginal leadership and governance and a high level of community
involvement in this successful mass drug administration program to address S. stercoralis. The
commitment required of these leaders was demanding, and involved intense work over a period
of several months. Apart from controlling strongyloidiasis, the community also takes pride in
having developed and implemented this program. This appears to be the first community-directed
S. stercoralis control program in Australia, and is an important part of the national story of controlling
infectious diseases in Indigenous communities.
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1. Background and Introduction
1.1. Background
This paper documents two historical phases of a community-directed Strongyloides stercoralis
control program. The first phase reports on a community-directed S. stercoralis control program in the
Indigenous community of Woorabinda, central Queensland Australia. The second phase documents
the need to have local Indigenous leadership and direction for community-wide health interventions,
and the importance of the researchers having cultural humility. Cultural humility is defined as
a lifelong process of self-reflection and self-critique whereby the individual not only learns about
another’s culture, but one starts with an examination of her/his own beliefs and cultural identities [1].
Cultural humility cannot be collapsed into a single workshop; it is commitment and active engagement
in a lifelong process ‘that individuals enter on an ongoing basis with patients, communities, colleagues,
and with themselves’ [1] (p. 118). This paper is a testament to Rick Speare’s cultural humility across
his research career.
Note that this paper is conspicuously published well after the first phase of this project. Following
a strongyloidiasis-related fatality, the first phase originally focused on the clinical outcomes of an
ivermectin mass drug administration [MDA] intervention to address S. stercoralis in the community.
However, while it was evident that ivermectin MDA clearly had a significant effect on decreasing
the prevalence of S. stercoralis among Woorabinda residents, the real success of this intervention lay
in the self-determination of the community and the community health team, who drove the health
promotion program to address strongyloidiasis in the community. Without this commitment from the
community health team, and their relationships and trust with community members, there would
have been little chance of the successful implementation of the ivermectin MDA.
This paper forms part of a new study that explores barriers and enablers to addressing infectious
diseases in Indigenous Australian communities. The community voiced their concerns regarding
participating in this study, as they felt: (i) they received no feedback from the original study relating to
the ivermectin MDA in their community, so the community requested some researchers from James
Cook University, in particular Rick Speare, to assist them with making sense of the data from the MDA,
and (ii) their story regarding the success of the community-driven approach to addressing the issue of
S. stercoralis received little attention. In their view, this was the most important aspect of the success of
this program.
To address this shortcoming and the failure in communication, the results of the MDA were
shared. The community felt that the community health team, in partnership with the community’s
leadership, was the real success of eradicating S. stercoralis in Woorabinda. On the community’s
invitation, a new research team travelled to Woorabinda to re-engage with community health team in
order to capture and share the story of their successful community-driven approach to address this
infectious disease, which impacted their community’s health and well-being.
1.2. Introduction
Strongyloidiasis is considered one of the most neglected tropical diseases and is estimated to affect
over 100 million people worldwide including Indigenous Australians [2,3]. Most cases are chronic,
while acute strongyloidiasis is more common in children [4,5]. Chronic strongyloidiasis increases the
risk of unpredictable fatal hyperinfection when patients become immunocompromised, malnourished,
or immunosuppressed. Hyperinfection can be caused by the administration of corticosteroids to
patients with strongyloidiasis [4,5].
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In Australia, strongyloidiasis is highly prevalent in Indigenous rural and remote communities,
and its management at the individual and community level is sub-optimal [6,7]. For S. stercoralis, a
prevalence greater than 5% is considered to be hyperendemic, and a public health intervention is
required [4,5]. However, although many Indigenous Australian communities appear to have above 5%
prevalence, no community-wide control program has been reported. This paper describes the outcome
from a community-based intervention to control strongyloidiasis, which was driven by the Aboriginal
community in partnership with the community health team.
1.3. Context
Woorabinda is a remote, Aboriginal community that is situated approximately 175 km southwest
of Rockhampton in Central Queensland, Australia (24◦08′05′ S 149◦27′22′ E). Woorabinda is the
traditional land of the Wadja and Wadjigal people. In 2005, this small discrete Indigenous community
had a population of at least 944, with about 191 western-style houses [8].
In 1996, an initial faecal survey for S. stercoralis and review of 130 hospital records indicated
an overall prevalence of 5% in the community, with the 5–9-year-old age group having the highest
prevalence of infection at 14% [9]. In 2000, the testing of patients presenting to the Woorabinda
Multipurpose Health Service showed that at least 12% were positive for S. stercoralis on faecal testing,
and 30% were positive on serology. In addition, a resident who was referred to a tertiary hospital for
treatment of another disease, died from hyperinfection.
The Woorabinda Multipurpose Health Service provided health care to the community through
a small hospital run by Queensland Health and an active community health team, the Woorabinda
Multipurpose Community Health Team. The majority of the team members were Indigenous
Australians with ancestral links to the area, and consisted of an Indigenous nurse, a non-Indigenous
nurse, several Aboriginal health workers (AHWs), and local residents employed in various roles.
2. Approach
In the original phase, the Woorabinda Multipurpose Community Health Team, in partnership
with the community, decided to initiate and lead a program to control S. stercoralis by involving the
whole Woorabinda community and using a combination of treatment and prevention strategies. The
goal of the program was to reduce the prevalence of S. stercoralis by at least 75% (from around an
estimated 30% prevalence to less than 7.5%), with complete elimination from Woorabinda being the
goal. The objectives were to: (i) implement a treatment program using agreed protocols; (ii) increase
community participation in strategies related to the prevention of S. stercoralis; and (iii) decrease
environmental risk factors contributing to S. stercoralis infection. The program was managed by a
steering committee that had members from the Woorabinda Health Service, Woorabinda Council, and
Central Queensland Public Health Unit; the committee also included community representatives, and
other people were co-opted as required. An advisory panel with specific technical expertise assisted
this steering committee.
A program work plan was co-developed, and is detailed in Table 1 to show as an example.
Awareness-raising and education about S. stercoralis were the first components of the project, and
only after the community was saturated with information did the treatment and testing stage begin.
Community-based health promotion is people-centered and collectivist [10]. This program involved
multiple stakeholders and worked across the community, as demonstrated by the engagement with
school and environmental health officers, the council, and community health service. Facilitation and
ownership of the program by the community assists with problem-solving, builds the capacity of the
community, and therefore enhances successful and sustainable programs [11].
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Table 1. Woorabinda S. stercoralis Control Program Work Plan.
Months After
Commencement Action Responsibility *
3–4 months
Formation of a steering committee DON
Adoption of program plan Steering committee
Appointment of personnel to conduct program DON
Develop consent forms: ivermectin, albendazole, beta-HCG
(test for pregnancy), release of information. PO/RN
Develop data collection tools for treatment—paper and
electronic PO/RN
Develop drug recording systems PO/RN
Develop management flow chart PO/RN
Develop education and awareness-raising materials PO/RN
Collect baseline data results from previous studies conducted
in Woorabinda and develop evaluation measures for
comparison:
(a) Environmental health and household survey;
(b) Animal census.
PO
Environmental health program commences EHO, EHCoordinator/HW’s/Council
Education and awareness-raising commences HW
6 months
Pilot of initial treatment DR/RN/HW
Review and modification of management flow chart Steering Committee
Environmental health program continues EHO, EHCoordinator/HW’s/Council
Initial serology/treatment of community DR/RN/HW
Follow-up of community members not presenting for
treatment/re-treatment of positive cases at two weeks RN/HW
Education and awareness-raising continues HW
Environmental health program continues EHO, EHCoordinator/HW’s/Council
Analysis of results from initial treatment and report RN
12–13 months
First follow-up serology and treatment of resistant/positive
cases. DR/RN/HW
Follow-up community members who have not presented for
serology and treatment/resistant cases RN/HW
Analysis of results from first follow-up and report RN
Second follow-up treatment for resistant cases DR/RN/HW
Follow-up community members not presenting for serology
and treatment RN/HW
Education and awareness raising continues HW
Environmental health program continues EHO, EHCoordinator/HW’s/Council
Analysis of results from second follow-up and report RN
14 months
Third follow-up serology and treatment DR/RN/HW
Follow-up community members not presenting for serology
and treatment RN/HW
Education and awareness raising continues HW
Environmental health program continues EHO, EHCoordinator/HW’s/Council
Analysis of results from third follow-up and report RN
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Table 1. Cont.
Months After
Commencement Action Responsibility *
21–24 months
Fourth follow-up serology DR/RN/HW
Follow-up community members not presenting for serology
and treatment RN/HW
Education and awareness raising continues HW
Environmental health program continues EHO, EHCoordinator/HW’s/Council
Analysis of results from fourth follow-up and report RN
Refer resistant cases to Dr RN
Final report and recommendations RN
Second yearly review to confirm eradication Health Service
* DON—Director of Nursing; PO—Project Officer; EHO—Environmental Health Officer; EH
Coordinator—Environmental Health Coordinator; DR—Doctor; Council—Local Shire Council; RN—Registered
Nurse; HW—Health Worker.
2.1. Community Participation
The Woorabinda Multipurpose Community Health Team worked with stakeholders to develop
health education and promotion material to ensure that all of the resources were culturally appropriate
and locally relevant. This material focused on explaining S. stercoralis and its lifecycle, symptoms of
strongyloidiasis, treatment, and prevention of transmission. Female community elders developed
several unique health promotion tools, including posters, a comic strip, and Aunty Val’s ‘Gunna
Story’ (Figure 1C). In local Aboriginal slang, ‘gunna’ means faeces. An explanation of the local
treatment program and prevention strategies encouraged people to play an active role in stopping
the transmission of S. stercoralis. These health promotion strategies used a multiple intervention
model and included: improvement of defects in sanitation systems by house-to-house inspection,
personal hygiene, safe disposal of nappies, wearing shoes, and responsible dog ownership. All of
these strategies were in line with the principles of the Ottawa Charter [12], which emphasises that
multiple strategies across sectors will assist in improving the health of peoples, groups, communities,
and populations. A recent study found that wearing shoes decreased the likelihood of infection of
schoolchildren with S. stercoralis [13].
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(A) Poster on protective footwear; (B) Jaime and Aunty June’s comic strip described the life cycle and
transmission of S. stercoralis; (C) Aunty Val’s Gunna Story; (D) Shoe barometer.
2.2. Involvement of Primary School Children
Teachers and children at the Woorabinda State Primary School were also actively involved. They
developed two very specific items: a shoe barometer that measured the percentage of children wearing
shoes to classes (Figure 2), and a Strongyloides song that was used on the local radio station, particularly
preceding announcements about the control program (Table 2). Health promotion programs are most
likely to be effective when they are flexible and responsive to local realities [11].
Table 2. The Strongyloides Song Developed and Sung by the Woorabinda State Primary Schoolchildren.
The Strongyloides Song
Words by June Barkworth and adapted by the Woorabinda Schoolchildren. The children and staff of the Woorabinda State
School wrote the music. This song was used as a signature tune to herald radio updates on the Strongyloides project.
No, no, no, ‘Mr Worm’ we don’t want you
Travelling through our skin and making us sick,
With boots and shoes on our feet (stamp, stamp)
Blankets on the ground,
We’re gon’na stop y u from moving around
‘Our bodies’
Yes, yes, yes, ‘Mr Worm’ y u have got to go ho, ho, ho, ho,
Go, go, go ‘Mr Worm’ we’re getting tough
You have no place to live in us.
We’re gon’na thrash you out, we’re gon’na move you on . . . . . . then
Woorabinda will say that ‘Mr Strongyloides’ worm is gone.
Yes, yes, yes ‘Mr Worm’ you have got to go. Ho, ho, ho, ho, ho.
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Figure 2. Prevalence of positive S. stercoralis serology from an initial survey in phase 1 of the
Woorabinda community, July–August 2004.
2.3. Treat-and-Test
All community residents were urged to participate in a ‘treat-and-test’ survey. Everyone was
asked for a sample of blood collected by venipuncture for S. stercoralis serology [14], and were treated
for S. stercoralis at this time. The most effective treatment for S. stercoralis is ivermectin [5,15], but
ivermectin is not licensed in Australia for treating pregnant women or children with a body weight
of less than 15 kg. A less effective alternative option, albendazole, can be used for treatment in the
latter category, but was not licensed in Australia for use in pregnant women. The treatment protocol
for the Woorabinda program was based on recommendations from the first National Workshop on
Strongyloidiasis in September 2001 [16]. This protocol recommended: (1) Children >6 months of age
but <10 kg, albendazole: 200 mg daily for three days; (2) Children >6 months of age and 10–15 kg,
albendazole: 400 mg daily for three days; and (3) All people except pregnant women >15 kg, ivermectin
(Stromectol): 0.2 mg/kg body weight. Women of child-bearing age were offered a pregnancy test prior
to treatment with ivermectin. Any person who was subsequently shown to have positive serology for
S. stercoralis on the initial blood sample was retreated within a month.
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2.4. Environmental Risk Factors
Environmental health activities were part of the community-wide program. A housing
improvement program as part of a state-wide initiative was operating in Woorabinda using
Commonwealth and State government funds. A set of priority areas was developed to address
environmental risk factors for S. stercoralis in the community. Specific actions included repairing
malfunctioning toilets and leaking taps and pipes that could cause areas of persistent damp soil.
2.5. Serological Results
Over a six-week period, 867 people were treated and tested; the group comprised 46% (404/867)
males, and 16.6% (144/867) (95% confidence interval 14.2–19.3) had positive serology. The parasite was
present in all age groups, with the highest percentage between 5–20 years, with a peak at 10–15 years
and a further rise at 50–59 years (Figure 2). The participation rate was approximately 92% (867/944).
Of the participants who tested positive in July and August 2004, 129 were re-tested in February
2005 after treatment, and 103 had reverted to negative: a cure rate of 79.8%. In February 2005, 140
people who had been initially negative for S. stercoralis were re-tested, and none had seroconverted
over this six-month period, indicating that transmission at Woorabinda appeared to have ceased.
3. Discussion
Most soil transmitted helminth (STH) control programs are driven and managed by health
departments, usually from urban centres. Although community-wide control programs for S. stercoralis
have been advocated since the 1990s [4,17], the only report outside the experimental situation appears
to be a Japanese study that monitored and treated a small group of residents on Okinawa, and hence
was not a program that engaged the whole community [18]. This Woorabinda program may be
the first community-wide program described. It was unusual in that it was initiated, implemented,
and managed by the community itself. Woorabinda found the resources—including the funding,
person-power, and expertise—that were needed for its successful completion. This was arguably the
key factor in achieving a high level of community engagement.
3.1. Impact of the Program
The strategy that was adopted was successful in identifying and treating much of the population.
The cure rate after two treatments was high, and transmission of S. stercoralis at Woorabinda appeared
to have ceased. This is the only description of a successful community-led S. stercoralis control
program. It appears to be the first to use a ‘treat-and-test’ strategy where all of the participants
were treated initially for S. stercoralis, and subsequent management depended on the test result.
Although the long-term effect of the program has not been evaluated, the Woorabinda health centre
doctor anecdotally reported to the research team that cases of strongyloidiasis are now rare, and
strongyloidiasis is no longer considered a public health issue at Woorabinda. Unfortunately, infection
with S. stercoralis is not notifiable in Australia; hence, the trend in incidence for Woorabinda is
unavailable. Making this parasitic infection notifiable is essential for control and elimination [19].
3.2. Local Leadership and Knowledge
The project team used Indigenous and local leadership, with AHW knowledge of the health profile
of the local community, the households, and the needs of the community being a very important factor
in the success of the mass drug administration program. Additionally, since the AHWs are community
members, trust between community members and health staff was high, giving the S. stercoralis control
program high credibility.
Trop. Med. Infect. Dis. 2018, 3, 48 9 of 11
3.3. Big Effort, But Worth It
Members of the health team worked very hard during this program, while still performing their
usual work tasks. However, they considered that the effort was worth it, since the disease of concern
was controlled, and the health team and the community became united on tackling and solving a
significant health problem. Over a decade later, yarns with original members of the health team still
reflect their sense of pride in their achievement.
3.4. Knowledge and Understanding of the Parasite
AHWs and other health staff providing information to community members about S. stercoralis
facilitated the development of localised knowledge and understanding of the parasite. This was
contextualised on the community’s prior knowledge about hookworm, a STH that had been historically
present in the community, but had been eliminated. This allowed the team to develop ways to share
new knowledge and understanding about S. stercoralis and the benefit of the program. Localised
communication strategies were developed and delivered in the form of novel health promotion
materials such as a children’s song, a children’s story in the local language, localised posters, radio
advertisements, and a school-based awareness program, which was exemplified by the shoe barometer.
The materials developed were a good illustration that in Aboriginal communities, health promotion
materials should be localised and humorised [20].
3.5. Development of an Inclusive Governance Model and Skills Development
The team developed a governance model to guide the project, which was a community-driven
approach that seconded expert advice at critical points of the program; the steering committee and
the advisory panel provided this advice. This approach fostered partnerships between the health and
education sectors, researchers, and local government. Strong support for serology tests was provided
by Queensland Health laboratory scientists at Rockhampton. AHWs were trained to collect blood
(except for infants and babies where phlebotomists were required), and standing orders gave the
AHWs authority to administer anthelmintic medications. An implementation protocol with a shared
understanding of the commitment required for this program was a core component of the program.
3.6. Aspects to Be Improved
A decrease in the number of people affected meant that momentum for the program to progress
to elimination was lost. Although a repeat community-wide survey to document the post-program
prevalence of strongyloidiasis would have provided valuable information, owing to lack of further
targeted resources, no survey was conducted.
4. Conclusions
This paper illustrates how a community-directed and led S. stercoralis control program using
a ‘treat-and-test’ strategy in a remote Australian Aboriginal community brought an outbreak and
subsequent high prevalence of strongyloidiasis under control. The use of localised health promotion
strategies and materials developed by community members contributed to the program’s success, and
set out a clear plan for action for other communities needing to address S. stercoralis. Since S. stercoralis
is usually not a health problem in developed countries and is usually associated with poverty, its high
prevalence in this community drew attention to the underlying social determinants of health and the
need for social solutions, as well as biomedical interventions.
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driving this MDA.
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